E71.542
Other group 3 peroxisomal disorders
Clinical Classification Guidelines
Medical Intelligence & Overview
Other group 3 peroxisomal disorders, classified under ICD-10 code E71.542, are rare genetic conditions that affect how the body breaks down certain fats and other molecules. These disorders are part of a larger group called peroxisomal disorders, which involve malfunctions in peroxisomes—tiny structures inside cells responsible for chemical reactions vital for health. People with these conditions may experience a range of symptoms, depending on the severity and specific nature of the disorder. Due to their rarity, these disorders often require specialized medical attention for diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting genes responsible for peroxisome function Inherited in an autosomal recessive pattern, meaning both parents must pass on the affected gene Disruptions in enzymes involved in lipid metabolism, leading to accumulation of certain fats in the body Possible environmental factors are not well-established due to the genetic nature of the disorder
Key Symptoms: Numbness or weakness in muscles Developmental delays or intellectual disabilities Distinctive facial features, such as a prominent forehead or flattening of the face Liver problems, including hepatomegaly (enlarged liver) Eye abnormalities, including vision problems or abnormalities in the retina Difficulty with coordination and balance Seizures in some cases Behavioral issues or developmental regression
Diagnostic & Treatment
Diagnosis Path: Diagnosis of other group 3 peroxisomal disorders typically involves multiple steps:
Treatment Protocols: Currently, there are no cures for peroxisomal disorders, but treatment mainly focuses on managing symptoms and improving quality of life:
Clinical Advice & FAQs
Billing Guidance
Is E71.542 a billable ICD-10 code?
Yes, E71.542 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E71.542?
Clinical documentation must specify the nature of Other group 3 peroxisomal disorders and any associated comorbidities for accurate reporting.
Cite this Clinical Reference